Thyroid eye disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 18-75 years old; Suffering from thyroid-related eye disease (TAO); TAO grade <= grade III; Can persist in observation for more than 2 months; Be able to understand the purpose of the trial, volunteer to participate in the researcher of this subject, and sign the informed consent form
Exclusion criteria
Exclusion criteria: History of other diseases other than hyperthyroidism, metabolic dysfunction, abnormal physical examination, or suspicious diseases or conditions found in clinical laboratory tests that may have contraindications to drug use or affect test results or make subjects prone to treatment complications, such as severe liver disease Impaired renal function and/or serious systemic diseases (such as cardiovascular system, respiratory system, digestive system, nervous system, endocrine system, genitourinary system diseases, etc.); Systemic infection under treatment; Liver and kidney dysfunction; History of drug abuse or alcoholism; Received drug clinical trials within 1 month (excluding vitamins and minerals); Any situation that the research doctor believes that the patient's condition will hinder the clinical trial (such as the patient is prone to mental stress, uncontrollable emotions, depression, etc.); Poor patient compliance, unable to complete the trial process as required.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| proptosis; | — |
Countries
China